Complications of androgen deprivation therapy in men with prostate cancer
β Scribed by Allen C. Chen; Daniel P. Petrylak
- Book ID
- 107546308
- Publisher
- Current Science Inc.
- Year
- 2004
- Tongue
- English
- Weight
- 315 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1523-3790
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The original article to which this Erratum refers was published in Cancer (2004) 101(3):541β9
## Abstract ## BACKGROUND. The use of androgen deprivation therapy (ADT) in the treatment of men with prostate cancer has risen sharply. Although cardiovascular disease is the most common reason for death among men with prostate cancer who do not die of the disease itself, data regarding the effec
## Background: As evidence accumulates in favor of androgen deprivation therapy (adt) in patients with recurrent or metastatic prostate carcinoma, concern has increased regarding bone loss associated with therapeutic hypogonadism. the current study described the natural history of bone complication